Literature DB >> 25656746

The role of varenicline on alcohol-primed self-administration and seeking behavior in rats.

Patrick A Randall1, Anel A Jaramillo, Suzanne Frisbee, Joyce Besheer.   

Abstract

RATIONALE: Varenicline, a smoking-cessation agent, may be useful in treating alcohol use disorders. An important consideration when studying factors that influence drinking/relapse is influence of the pharmacological effects of alcohol on these behaviors. Pre-exposure to alcohol (priming) can increase craving, drinking, and seeking behaviors.
OBJECTIVES: The primary goal of this work was to determine the effects of varenicline on alcohol-primed self-administration and seeking behavior in male Long-Evans rats.
METHODS: First, we assessed whether varenicline (0, 0.3, 1, 3 mg/kg, IP) has alcohol-like discriminative stimulus effects and whether varenicline alters sensitivity to alcohol in rats trained to discriminate a moderate alcohol dose (1 g/kg, IG) vs. water. Second, animals trained to self-administer alcohol underwent assessments to test the effects of: (i) varenicline (0, 0.3, 1, 3 mg/kg, IP) on self-administration, (ii) alcohol priming (0, 0.3, 1 g/kg, IG) on self-administration and seeking behavior, and (iii) varenicline (1 mg/kg) in combination with alcohol priming (1 g/kg) on these behaviors.
RESULTS: Varenicline did not substitute for alcohol but disrupted the expression of sensitivity to alcohol. Varenicline decreased self-administration but only at a motor-impairing dose (3 mg/kg). Alcohol priming decreased self-administration and seeking behavior. Varenicline (1 mg/kg) blocked this effect under self-administration conditions, but not seeking conditions, which effectively resulted in increased alcohol intake.
CONCLUSIONS: These findings suggest the importance of further behavioral and mechanistic studies to evaluate the use of varenicline in treating alcohol use disorders and its potential impact on drinking patterns in smokers using varenicline as a smoking-cessation aid.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25656746      PMCID: PMC4482789          DOI: 10.1007/s00213-015-3878-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  55 in total

Review 1.  Nicotine addiction and comorbidity with alcohol abuse and mental illness.

Authors:  John A Dani; R Adron Harris
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

2.  Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition.

Authors:  Hans Rollema; Mihály Hajós; Patricia A Seymour; Rouba Kozak; Mark J Majchrzak; Victor Guanowsky; Weldon E Horner; Doug S Chapin; William E Hoffmann; David E Johnson; Stafford McLean; Jody Freeman; Kathryn E Williams
Journal:  Biochem Pharmacol       Date:  2009-06-06       Impact factor: 5.858

Review 3.  Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.

Authors:  Jing Liang; Richard W Olsen
Journal:  Acta Pharmacol Sin       Date:  2014-08       Impact factor: 6.150

4.  Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments.

Authors:  F C Colpaert; C J Niemegeers; P A Janssen
Journal:  Pharmacol Biochem Behav       Date:  1979-04       Impact factor: 3.533

5.  Drug-induced reinstatement of extinguished self-administration behavior in monkeys.

Authors:  G J Gerber; R Stretch
Journal:  Pharmacol Biochem Behav       Date:  1975 Nov-Dec       Impact factor: 3.533

6.  Stress hormone exposure reduces mGluR5 expression in the nucleus accumbens: functional implications for interoceptive sensitivity to alcohol.

Authors:  Joyce Besheer; Kristen R Fisher; Anel A Jaramillo; Suzanne Frisbee; Reginald Cannady
Journal:  Neuropsychopharmacology       Date:  2014-04-09       Impact factor: 7.853

7.  Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption.

Authors:  Linzy M Hendrickson; Rubing Zhao-Shea; Xueyan Pang; Paul D Gardner; Andrew R Tapper
Journal:  J Neurosci       Date:  2010-07-28       Impact factor: 6.167

8.  Effects of alcohol and lorazepam during extinction of alcohol self-administration in rats.

Authors:  Anne Jackson; Theodora Duka; David N Stephens
Journal:  J Psychopharmacol       Date:  2003-09       Impact factor: 4.153

9.  Transient increase in alcohol self-administration following a period of chronic exposure to corticosterone.

Authors:  Joyce Besheer; Kristen R Fisher; Tessa G Lindsay; Reginald Cannady
Journal:  Neuropharmacology       Date:  2013-05-03       Impact factor: 5.250

10.  An epidemiologic analysis of co-occurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Daniel E Falk; Hsiao-ye Yi; Susanne Hiller-Sturmhöfel
Journal:  Alcohol Res Health       Date:  2006
View more
  18 in total

1.  Functional role for cortical-striatal circuitry in modulating alcohol self-administration.

Authors:  Anel A Jaramillo; Patrick A Randall; Spencer Stewart; Brayden Fortino; Kalynn Van Voorhies; Joyce Besheer
Journal:  Neuropharmacology       Date:  2017-11-26       Impact factor: 5.250

2.  Effect of Varenicline Combined with High-Dose Alcohol on Craving, Subjective Intoxication, Perceptual Motor Response, and Executive Cognitive Function in Adults with Alcohol Use Disorders: Preliminary Findings.

Authors:  Terril L Verplaetse; Brian P Pittman; Julia M Shi; Jeanette M Tetrault; Sabrina Coppola; Sherry A McKee
Journal:  Alcohol Clin Exp Res       Date:  2016-06-01       Impact factor: 3.455

Review 3.  Interactions between nicotine and drugs of abuse: a review of preclinical findings.

Authors:  Stephen J Kohut
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-02       Impact factor: 3.829

4.  The Effects of Long-Term Varenicline Administration on Ethanol and Sucrose Seeking and Self-Administration in Male P Rats.

Authors:  Cristine L Czachowski; Janice C Froehlich; Michael DeLory
Journal:  Alcohol Clin Exp Res       Date:  2017-12-23       Impact factor: 3.455

Review 5.  New steps for treating alcohol use disorder.

Authors:  Erin J Campbell; Andrew J Lawrence; Christina J Perry
Journal:  Psychopharmacology (Berl)       Date:  2018-03-25       Impact factor: 4.530

6.  Effect of Lowering the Dose of Varenicline on Alcohol Self-administration in Drinkers With Alcohol Use Disorders.

Authors:  Terril L Verplaetse; Brian P Pittman; Julia M Shi; Jeanette M Tetrault; Sabrina Coppola; Sherry A McKee
Journal:  J Addict Med       Date:  2016 May-Jun       Impact factor: 3.702

Review 7.  The role of nicotinic acetylcholine receptors in alcohol-related behaviors.

Authors:  C N Miller; H M Kamens
Journal:  Brain Res Bull       Date:  2020-07-22       Impact factor: 4.077

8.  Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.

Authors:  Ryan T Hurt; Jon O Ebbert; Ivana T Croghan; Darrell R Schroeder; Richard D Hurt; J Taylor Hays
Journal:  Drug Alcohol Depend       Date:  2018-01-02       Impact factor: 4.492

9.  Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.

Authors:  Giulia Scuppa; Andrea Cippitelli; Lawrence Toll; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Drug Alcohol Depend       Date:  2015-09-08       Impact factor: 4.492

10.  Effects of varenicline on operant self-administration of alcohol and/or nicotine in a rat model of co-abuse.

Authors:  D Funk; S Lo; K Coen; A D Lê
Journal:  Behav Brain Res       Date:  2015-09-11       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.